Description: In this AUW-inspiring session, we'll dive into a decade-worth of accelerated underwriting (AUW) random holdout and post-issue audit data collected across 30+ industry programs and learn monitoring best practices directly from two life insurance underwriting experts on the 'front lines' of monitoring. From the industry study, we'll explore misclassification trends, including the characteristics of applicants most likely to be misclassified in a random audit and how we use this monitoring data to estimate excess mortality 'slippage' in AUW programs. From first-hand experience, underwriters will highlight the challenges and benefits of various monitoring methods, including resource constraints and how targeted auditing can be leveraged to guide future program enhancements. Lastly, we'll discuss when year-over-year trends and claims experience become credible, and in the meantime, how to look for value beyond the slippage estimate to improve fluidless underwriting programs moving forward into the next decade and beyond! Learning outcomes: 1) Gain a solid understanding of common monitoring practices in accelerated underwriting programs 2) Explore an in-depth monitoring study of 30,000+ random holdout and post-issue audit cases across 30+ AUW programs spanning over a decade of issue years 3) Learn how to use monitoring data to estimate excess mortality 'slippage' in AUW programs 4) Discover how monitoring insights and techniques can be leveraged to improve fluidless underwriting programs moving forward

Description: Modern actuarial work, being quite data intensive, provides many opportunities for actuaries to use the statistical skills that are part of their basic training. Furthermore, modern computing allows us to analyze vast quantities of data intensively, and each package will provide statistical 'answers' to any questions the actuary might ask of it.

Description: Medicare Advantage plans have been in the market for two decades. In this session, we survey the landscape changes from 2006 up to now, which include but not limited to the changes of enrollment, plan types, big players' market share, policies, and how players as well as beneficiaries react to the changes. This session intends to provide general MA knowledge and history to the audience with or without Medicare Advantage background.

Description: Renal disease is a very heterogenous medical condition whose end state is dialysis, a recurring cost intensive medical condition. Dialysis cost is one of the major medical cost drivers in USA. Insufficient and improper care management in the early stages of CKD (chronic kidney disease) leads to early incidence of end stage renal disease (ESRD) among CKD patients which not only leads to high medical costs, but also reflects poor health quality.

Description: Get an in-depth explanation on how data scientists and actuaries can work together to battle the issues arising from big data. Join our focus on the insurance industry as a whole and look at data scientists' and actuaries' roles from the views of different areas of the industry. We will also focus on how data science can be a valuable tool for actuaries. After the session, you will be able to understand: - How developments in data science are shaping Insurance Industry practices - How data scientists can help actuaries - How data science can be used to improve analysis of industry experience

Description: In summer 2021, the SOA Research Institute’s Mortality and Longevity Strategic Research Program sponsored a webcast examining individual life and group life emerging mortality in a COVID-19 world. Since then, Delta and Omicron coronavirus variants have fueled waves of the virus in the U.S., boosting the total number of COVID-19 deaths since the beginning of the pandemic to near the 1 million mark. Hear an update and insights into how the life insured population is faring during COVID-19 by discussing the findings from two recent SOA Research Institute initiatives. LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA) and TAI have collaborated to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience. Additionally, the SOA Research Institute has surveyed insurers to gather a high-level view of U.S. Group Term Life Insurance mortality results during the COVID-19 pandemic, comparing them to pre-pandemic mortality levels. The Group Term Life industry mortality results will be presented with monthly data through March 2022.

Description: "Demographic components of Future Potential Old-Age Support Ratios – Kirill Andreev, Ph.D., United Nations, Population Division, New York, Mila Andreeva, KAMA Consulting Effect of internal Migration on the Health of Taiwan’s Elderly People – Jack C. Yue, Ph.D., – National Chengchi University, Department of Statistics, Taipei, TaiwanPopulation Aging and Canada’s Social Contract: Covid-19 Catalyst for Change – Douglas Andrews, FSA, FCIA, Ph.D., Lori J. Curtis, Ph.D., – University of Waterloo"

Description: "Establishing Methods for Annual Updates to Cohort Life Expectancies – R. Dale Hall, FSA, CERA, MAAAManaging Director of Research, Society of Actuaries Research Institute Longevity Disparity across Communities in the United States – Lijia Guo, Ph.D., ASA, MAAA , US Government Accountability Office, Applied Research and Methods Division, Washington DC"

Description: Both the SOA and AARP will showcase their recent research projects highlighting the impact of marginalization on aging and retirement. Learn how being a member of a marginalized group changes your outcomes as well as your perspective on aging and retirement.

Description: Our understanding of the biology of aging is increasing rapidly, creating insight into how and why any organism is aging. Some of the mechanisms by which the process of aging occurs in mammals are sufficiently well understood that clinical trials targeting them in humans to improve later life health and longevity are now being undertaken. Translating results seen in mammals to humans has the potential to increase life expectancy far beyond what we have seen historically. Come explore the current state and outlook of research.